Emergent Biosolutions: Q4 Earnings Snapshot
By AP News
Published - Mar 06, 2024, 05:21 PM ET
Last Updated - Mar 06, 2024, 05:21 PM EST
GAITHERSBURG, Md. (AP) — GAITHERSBURG, Md. (AP) — Emergent Biosolutions Inc. (EBS) on Wednesday reported a loss of $49.5 million in its fourth quarter.
The Gaithersburg, Maryland-based company said it had a loss of 95 cents per share. Losses, adjusted for one-time gains and costs, came to 77 cents per share.
The biopharmaceutical company posted revenue of $276.6 million in the period.
For the current quarter ending in March, Emergent Biosolutions said it expects revenue in the range of $200 million to $250 million.
